Grantham, Mayo, Van Otterloo & Co (GMO)’s Colgate-Palmolive CL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-250,000	Closed	-$16.7M	–	542
2018 Q3	$16.7M	Hold	250,000	–	–	0.11%	117
2018 Q2	$16.2M	Buy	250,000 +90,000	+56%	+$5.89M	0.12%	120
2018 Q1	$11.5M	Sell	160,000 -61,000	-28%	-$4.39M	0.07%	145
2017 Q4	$16.7M	Sell	221,000 -39,000	-15%	-$2.85M	0.1%	121
2017 Q3	$18.9M	Buy	+260,000	New	+$18.7M	0.11%	118

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CL Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Colgate-Palmolive (CL) stake by 9.1% in Q1 2026, buying an estimated $329K and bringing the position to 44,252 shares worth $3.77M. The position accounts for 0.01% of the portfolio, ranked #359.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CL in Q2 2013 and has held it in 43 quarters since. The position peaked at $727M in Q2 2013. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 44,252 shares of Colgate-Palmolive worth $3.77M as of Q1 2026.
Grantham, Mayo, Van Otterloo & Co (GMO) bought 3,687 Colgate-Palmolive shares in Q1 2026, an estimated $329K.
Colgate-Palmolive made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #359 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 43 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Colgate-Palmolive position peaked at $727M in Q2 2013.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.